Patent Term Extensions shall have the meaning set forth in Section 11.9.
Patent Term Extensions means the interim or permanent extension ofthe term of any Licensed Patents or claims covered by any Licensed Patents for any Licensed Product for which MAYO may be eligible under 35 U.S.C. § 156 or any otherU.S. or non-U.S. statute providing for extensions of patent terms;
Patent Term Extensions means any and all extensions of a term of a Patent granted under the Patent laws or regulations of any country, the European Union, or any other Governmental Entity;
Examples of Patent Term Extensions in a sentence
If elections with respect to obtaining Patent Term Extensions are to be made, [***] shall have the sole and exclusive right to make such elections with respect to Roche Patent Rights, Joint Patent Rights and GBT Patent Rights.
The Parties shall cooperate with each other in obtaining Patent Term Extensions wherever and whenever applicable.
See Ann Kotze, “Reining in Patent Term Extensions for Related Pharmaceutical Products Post- Photocure and Ortho- McNeil,” 106 Northwestern University Law Review (2012), 1419.
The Party that does not apply for an extension under this Section 10.5 (Patent Term Extensions) shall cooperate fully with the other Party in making such filings or actions, for example making available all required regulatory data and information and executing any required authorizations to apply for such patent term extension.
Entrants consent to UTS:Library using their name, image or voice for promotional purposes.
More Definitions of Patent Term Extensions
Patent Term Extensions means any and all extensions of a term of a Patent granted under the Patent laws or regulations of any country, the European Union (including any supplementary protection certificate), or any other Governmental Entity;
Patent Term Extensions has the meaning assigned to it in Section 5.3.
Patent Term Extensions means all available patent term extensions, adjustments or restorations, or supplementary protection certificates. Regeneron shall have the sole right, but not the obligation, to file for Patent Term Extensions with respect to the Products in the Regeneron Patent Territory. The Parties will share all of Regeneron’s [* * *] for such Patent Term Extensions [* * *]. Roche shall have the sole right, but not the obligation, to file for Patent Term Extensions, including Supplementary Protection Certifications, with respect to the Products in the Roche Territory; provided, that if filing for any such Patent Term Extension would reasonably be expected to have a negative impact on the Product in the US then Regeneron’s prior approval, in its sole discretion, shall be required for such Patent Term Extension. The Parties will share all of Roche’s [* * *] for such Patent Term Extensions [* * *]. With respect to Patent Term Extensions with respect to the Products in the Roche Territory, subject to Roche obtaining Regeneron’s approval if necessary, Regeneron shall (a) xxxxx Xxxxx the right to file for such Patent Term Extension and (b) execute such authorizations and other documents and take such other actions as may be reasonably requested by Roche to obtain such Patent Term Extensions. Each Party shall execute such authorizations and other documents and take such other actions as may be reasonably requested by the other Party to obtain such Patent Term Extensions. The Parties shall cooperate with each other in gaining Patent Term Extensions with respect to the Products. With respect to any filings made to Regulatory Authorities with respect to any Compounds or Products, including, as required or allowed in the US, the FDA’s Purple Book, if applicable, or outside the US, other international equivalents, Regeneron will have the sole right to make any such decision whether to list Regeneron Patent Rights, but in all events will comply with Applicable Law, provided that Regeneron will consider in good faith any timely comments received from on behalf of Roche with respect to such filings in the Roche Territory prior to submission. Upon Regeneron’s request, Roche will reasonably cooperate in the implementation of Regeneron’s decision made under this Section 14.16.
Patent Term Extensions. Section 9.3.
Patent Term Extensions shall have the meaning set forth in Section 5.06(a). “Payment Recipient” has the meaning set forth in Section 8.14(a).
Patent Term Extensions shall have the meaning given in Section 8.4. *** Material has been omitted pursuant to a request for confidential treatment and such material has been filed separately with the SEC.
Patent Term Extensions has the meaning set forth in Section 14.3. 1.71 “Permitted Sublicensees” has the meaning set forth in Section 2.9. 1.72 “Person” means an individual, sole proprietorship, partnership, limited partnership, limited liability partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture or other legal entity or organization, including a government or political subdivision, department, or agency of a government. 1.73 “Primary Packaging” means the foil pouch that individually wraps and touches each Unit. 1.74 “Primary Packaging Design” means artwork associated with the Primary Packaging for the Product in the Territory. 1.75 “Product” means Aquestive’s Exservan™ (riluzole oral soluble film) product in the Dosage Strength.